- Home
- RMTI vs RAND Comparison
RMTI vs RAND Comparison
Compare RMTI & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMTI | RAND |
|---|---|---|
| Founded | 1994 | 1969 |
| Country | United States | United States |
| Employees | 300 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 32.4M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RMTI | RAND |
|---|---|---|
| Price | $0.90 | $12.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 241.3K | 3.6K |
| Earning Date | 04-27-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 9.46% |
| EPS Growth | ★ 91.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $101,489,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.38 | N/A |
| 52 Week Low | $0.78 | $10.05 |
| 52 Week High | $2.10 | $25.34 |
Technical Indicators
Market Signals| Indicator | RMTI | RAND |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 56.26 |
| Support Level | $0.80 | $10.56 |
| Resistance Level | $1.02 | $12.50 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 33.04 | 82.23 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.